ACADIA Pharmaceuticals (ACAD)
|
6.00
+0.01 (+0.17%)
|
|
|
|
ACAD additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACAD Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Fidelity Growth Company
DFA U.S. Small Cap Value II
Vanguard Extended Market Idx
SEI Instl Invt Small/Mid Cap Equity A
Bridgeway Ultra-Small Company Market
Fidelity Select Biotechnology
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Vantagepoint Discovery
Fidelity Spartan Extended Mkt Index Inv
DFA US Small Cap I
DFA U.S. Small Cap Value II
Vanguard Extended Market Idx
SEI Instl Invt Small/Mid Cap Equity A
Bridgeway Ultra-Small Company Market
Fidelity Select Biotechnology
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Vantagepoint Discovery
Fidelity Spartan Extended Mkt Index Inv
DFA US Small Cap I
•
Executives
Dr. Uli Hacksell Ph.D.
Chief Exec. Officer
Pres and Director
Mr. Thomas H. Aasen CPA
Chief Financial Officer
Chief Bus. Officer Principal Accounting Officer Exec. VP and Treasurer
Mr. Glenn F. Baity
VP
Gen. Counsel Corp. Compliance Officer and Sec.
Dr. Roger G. M. Mills M.D.
Exec. VP of Devel.
Chief Exec. Officer
Pres and Director
Mr. Thomas H. Aasen CPA
Chief Financial Officer
Chief Bus. Officer Principal Accounting Officer Exec. VP and Treasurer
Mr. Glenn F. Baity
VP
Gen. Counsel Corp. Compliance Officer and Sec.
Dr. Roger G. M. Mills M.D.
Exec. VP of Devel.
•
Employee Count
24
Special Offers
Competitors
ACAD earnings
Date
Actual
Expected
Prev Yr Qtr
11/5/2012
-0.04
-0.09
-0.10
8/8/2012
-0.10
-0.12
-0.12
5/8/2012
-0.12
-0.11
-0.12
